ub.xmlui.mirage2.page-structure.muninLogoub.xmlui.mirage2.page-structure.openResearchArchiveLogo
    • EnglishEnglish
    • norsknorsk
  • Velg spraakEnglish 
    • EnglishEnglish
    • norsknorsk
  • Administration/UB
View Item 
  •   Home
  • Det helsevitenskapelige fakultet
  • Institutt for klinisk medisin
  • Artikler, rapporter og annet (klinisk medisin)
  • View Item
  •   Home
  • Det helsevitenskapelige fakultet
  • Institutt for klinisk medisin
  • Artikler, rapporter og annet (klinisk medisin)
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

PET imaging of the adenosine A2A receptor in the rotenone-based mouse model of Parkinson’s disease with [18F]FESCH synthesized by a simplified two-step one-pot radiolabeling strategy

Permanent link
https://hdl.handle.net/10037/18608
DOI
https://doi.org/10.3390/molecules25071633
Thumbnail
View/Open
article.pdf (2.910Mb)
Published version (PDF)
Date
2020-04-02
Type
Journal article
Tidsskriftartikkel
Peer reviewed

Author
Schröder, Susann; Lai, Thu Hang; Toussaint, Magali; Kranz, Mathias; Chovsepian, Alexandra; Shang, Qi; Dukić-Stefanović, Sladjana; Deuther-Conrad, Winnie; Teodoro, Rodrigo; Wenzel, Barbara; Moldovan, Rareş-Petru; Pan-Montojo, Francisco; Brust, Peter
Abstract
The adenosine A2A receptor (A2AR) is regarded as a particularly appropriate target for non-dopaminergic treatment of Parkinson’s disease (PD). An increased A2AR availability has been found in the human striatum at early stages of PD and in patients with PD and dyskinesias. The aim of this small animal positron emission tomography/magnetic resonance (PET/MR) imaging study was to investigate whether rotenone-treated mice reflect the aspect of striatal A2AR upregulation in PD. For that purpose, we selected the known A2AR-specific radiotracer [18F]FESCH and developed a simplified two-step one-pot radiosynthesis. PET images showed a high uptake of [18F]FESCH in the mouse striatum. Concomitantly, metabolism studies with [18F]FESCH revealed the presence of a brain-penetrant radiometabolite. In rotenone-treated mice, a slightly higher striatal A2AR binding of [18F]FESCH was found. Nonetheless, the correlation between the increased A2AR levels within the proposed PD animal model remains to be further investigated.
Publisher
MDPI
Citation
Schröder, Lai, Toussaint M, Kranz M, Chovsepian, Shang, Dukić-Stefanović S, Deuther-Conrad W, Teodoro R, Wenzel B, Moldovan, Pan-Montojo, Brust P. PET imaging of the adenosine A2A receptor in the rotenone-based mouse model of Parkinson’s disease with [18F]FESCH synthesized by a simplified two-step one-pot radiolabeling strategy. Molecules. 2020;25:1633(7):1-15
Metadata
Show full item record
Collections
  • Artikler, rapporter og annet (klinisk medisin) [1974]
Copyright 2020 The Author(s)

Browse

Browse all of MuninCommunities & CollectionsAuthor listTitlesBy Issue DateBrowse this CollectionAuthor listTitlesBy Issue Date
Login

Statistics

View Usage Statistics
UiT

Munin is powered by DSpace

UiT The Arctic University of Norway
The University Library
uit.no/ub - munin@ub.uit.no

Accessibility statement (Norwegian only)